181 related articles for article (PubMed ID: 38308969)
1. The role of microbial metabolites in endocrine tumorigenesis: From the mechanistic insights to potential therapeutic biomarkers.
Zhang Y; Tang N; Zhou H; Zhu Y
Biomed Pharmacother; 2024 Mar; 172():116218. PubMed ID: 38308969
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota-derived short-chain fatty acids regulate gastrointestinal tumor immunity: a novel therapeutic strategy?
Dong Y; Zhang K; Wei J; Ding Y; Wang X; Hou H; Wu J; Liu T; Wang B; Cao H
Front Immunol; 2023; 14():1158200. PubMed ID: 37122756
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs).
Ratajczak W; Rył A; Mizerski A; Walczakiewicz K; Sipak O; Laszczyńska M
Acta Biochim Pol; 2019 Mar; 66(1):1-12. PubMed ID: 30831575
[TBL] [Abstract][Full Text] [Related]
4. Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases.
Ashique S; De Rubis G; Sirohi E; Mishra N; Rihan M; Garg A; Reyes RJ; Manandhar B; Bhatt S; Jha NK; Singh TG; Gupta G; Singh SK; Chellappan DK; Paudel KR; Hansbro PM; Oliver BG; Dua K
Chem Biol Interact; 2022 Dec; 368():110231. PubMed ID: 36288778
[TBL] [Abstract][Full Text] [Related]
5. The role of key gut microbial metabolites in the development and treatment of cancer.
Jaye K; Li CG; Chang D; Bhuyan DJ
Gut Microbes; 2022; 14(1):2038865. PubMed ID: 35220885
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the Tumor Microenvironment by Microbiota-Derived Short-Chain Fatty Acids: Impact in Colorectal Cancer Therapy.
Gomes S; Rodrigues AC; Pazienza V; Preto A
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982144
[TBL] [Abstract][Full Text] [Related]
7. Regulation of CD4
Schiweck C; Edwin Thanarajah S; Aichholzer M; Matura S; Reif A; Vrieze E; Weigert A; Visekruna A
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955407
[TBL] [Abstract][Full Text] [Related]
8. Dual role of microbiota-derived short-chain fatty acids on host and pathogen.
Mirzaei R; Dehkhodaie E; Bouzari B; Rahimi M; Gholestani A; Hosseini-Fard SR; Keyvani H; Teimoori A; Karampoor S
Biomed Pharmacother; 2022 Jan; 145():112352. PubMed ID: 34840032
[TBL] [Abstract][Full Text] [Related]
9. Role of microbiota-derived short-chain fatty acids in nervous system disorders.
Mirzaei R; Bouzari B; Hosseini-Fard SR; Mazaheri M; Ahmadyousefi Y; Abdi M; Jalalifar S; Karimitabar Z; Teimoori A; Keyvani H; Zamani F; Yousefimashouf R; Karampoor S
Biomed Pharmacother; 2021 Jul; 139():111661. PubMed ID: 34243604
[TBL] [Abstract][Full Text] [Related]
10. Gut microbial metabolites SCFAs and chronic kidney disease.
He M; Wei W; Zhang Y; Xiang Z; Peng D; Kasimumali A; Rong S
J Transl Med; 2024 Feb; 22(1):172. PubMed ID: 38369469
[TBL] [Abstract][Full Text] [Related]
11. Anticancer Effects of Gut Microbiota-Derived Short-Chain Fatty Acids in Cancers.
Son MY; Cho HS
J Microbiol Biotechnol; 2023 Jul; 33(7):849-856. PubMed ID: 37100764
[TBL] [Abstract][Full Text] [Related]
12. The impact of microbiota-derived short-chain fatty acids on macrophage activities in disease: Mechanisms and therapeutic potentials.
Duan H; Wang L; Huangfu M; Li H
Biomed Pharmacother; 2023 Sep; 165():115276. PubMed ID: 37542852
[TBL] [Abstract][Full Text] [Related]
13. Intracerebroventricular Delivery of Gut-derived Microbial Metabolites in Freely Moving Mice.
Liou CW; Yao TH; Wu WL
J Vis Exp; 2022 Jun; (184):. PubMed ID: 35723471
[TBL] [Abstract][Full Text] [Related]
14. Short chain fatty acids: Microbial metabolites for gut-brain axis signalling.
O'Riordan KJ; Collins MK; Moloney GM; Knox EG; Aburto MR; Fülling C; Morley SJ; Clarke G; Schellekens H; Cryan JF
Mol Cell Endocrinol; 2022 Apr; 546():111572. PubMed ID: 35066114
[TBL] [Abstract][Full Text] [Related]
15. How Dietary Fibre, Acting via the Gut Microbiome, Lowers Blood Pressure.
Xu C; Marques FZ
Curr Hypertens Rep; 2022 Nov; 24(11):509-521. PubMed ID: 35838884
[TBL] [Abstract][Full Text] [Related]
16. Sodium butyrate in both prevention and supportive treatment of colorectal cancer.
Kaźmierczak-Siedlecka K; Marano L; Merola E; Roviello F; Połom K
Front Cell Infect Microbiol; 2022; 12():1023806. PubMed ID: 36389140
[TBL] [Abstract][Full Text] [Related]
17. Capacity of a Microbial Synbiotic To Rescue the
Tierney BT; Van den Abbeele P; Al-Ghalith GA; Verstrepen L; Ghyselinck J; Calatayud M; Marzorati M; Gadir AA; Daisley B; Reid G; Bron PA; Gevers D; Dhir R; Simmons SL
Appl Environ Microbiol; 2023 Mar; 89(3):e0188022. PubMed ID: 36840551
[TBL] [Abstract][Full Text] [Related]
18. The neuropharmacology of butyrate: The bread and butter of the microbiota-gut-brain axis?
Stilling RM; van de Wouw M; Clarke G; Stanton C; Dinan TG; Cryan JF
Neurochem Int; 2016 Oct; 99():110-132. PubMed ID: 27346602
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota modulate CD8
Yu X; Ou J; Wang L; Li Z; Ren Y; Xie L; Chen Z; Liang J; Shen G; Zou Z; Zhao C; Li G; Hu Y
Gut Microbes; 2024; 16(1):2307542. PubMed ID: 38319728
[TBL] [Abstract][Full Text] [Related]
20. Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer.
Zhang SL; Mao YQ; Zhang ZY; Li ZM; Kong CY; Chen HL; Cai PR; Han B; Ye T; Wang LS
Theranostics; 2021; 11(9):4155-4170. PubMed ID: 33754054
[No Abstract] [Full Text] [Related]
[Next] [New Search]
